Invokana lawsuits will remain in the Philadelphia federal court according to a recent ruling. Invokana, a prescription medication to treat diabetes, is meant to help control blood sugars and lower A1C in adults. However, it’s been linked to serious side effects including: Ketoacidosis Urinary tract infections Kidney problems Cardiovascular problems Ketoacidosis is extremely concerning. It requires hospitalization and may result
The Invokana kidney disease phenomenon continues to cause concern throughout the research and medical communities. In 2016, the European Medicines Agency (EMA) announced that they too noticed the Invokana kidney disease link. In 2015, the Institute for Safe Medication Practices reported 457 adverse events. These adverse events included urinary tract infections, kidney stones, dehydration, abnormal weight loss, and kidney disease.
Janssen Pharmaceuticals, a division of Johnson & Johnson, released Invokana in 2013. At the time, Invokana was widely accepted by doctors and patients with Type 2 Diabetes as a way that they could get blood sugar under control, even if the patient had a higher A1C level. The goal of Invokana was to block excess sugar from making it into
Invokana, once hailed as the ‘miracle drug’ for treating Type 2 diabetes, is now the subject of a series of lawsuits. The Invokana lawsuit alleges that the potential development of ketoacidosis and other side effects were not properly disclosed to patients looking to treat their adult onset diabetes. Invokana May Cause Kidney Failure And Nerve Damage Two of the main
Invokana, a medication used to help control Type 2 diabetes, recently received another warning label courtesy of the FDA. The new, stronger warning from the FDA alerts patients to the risk of ketoacidosis and kidney damage. The FDA stated, “Based on recent reports, we have revised the warnings in the drug labels to include information about acute kidney injury and